In a report released yesterday, Allen Klee from Maxim Group reiterated a Buy rating on Marpai (MRAI – Research Report), with a price target of $2.50. The company's shares closed last Friday at $0.88, close to its 52-week low of $0.74. According to TipRanks.com, Klee 's ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -23.5% and a 20.5% success rate. Klee covers the Technology sector, focusing on stocks such as CareCloud, Inc., Iveda Solutions, and Mitek Systems. Currently, the analyst consensus on Marpai is a Moderate Buy with an average price target of $2.50.
https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-their-buy-rating-for-marpai-mrai?utm_source=advfn.com&utm_medium=referral
Marpai (NASDAQ:MRAI)
Historical Stock Chart
From Jul 2022 to Aug 2022 Click Here for more Marpai Charts.
Marpai (NASDAQ:MRAI)
Historical Stock Chart
From Aug 2021 to Aug 2022 Click Here for more Marpai Charts.